PMID: 825Dec 1, 1975

Engraftment of allogeneic dog bone marrow

Transplantation Proceedings
H M VriesendorpD W van Bekkum


Resistance to allogeneic bone-marrow grafts (AR) was found to occur in many species, including the dog. The i.v. administration of silica particles suppressed AR in vivo in this species. Genetic studies provide suggestive evidence for the existence of a previously unrecognized system or systems in the canine major histocompatibility complex controlling AR.

Related Concepts

Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine)
Asparaginase medac
Complete Blood Count
Blood Platelets
Bone Marrow Cells
Carcinoembryonic Antigen
Canis familiaris
Graft Vs Host Reaction
SD Antigens

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.